142 related articles for article (PubMed ID: 18824006)
21. Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation.
Aranha MM; Solá S; Low WC; Steer CJ; Rodrigues CM
J Cell Biochem; 2009 Jul; 107(4):748-58. PubMed ID: 19415678
[TBL] [Abstract][Full Text] [Related]
22. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions?
Mark WY; Liao JC; Lu Y; Ayed A; Laister R; Szymczyna B; Chakrabartty A; Arrowsmith CH
J Mol Biol; 2005 Jan; 345(2):275-87. PubMed ID: 15571721
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells.
Mahmud DL; G-Amlak M; Deb DK; Platanias LC; Uddin S; Wickrema A
Oncogene; 2002 Feb; 21(10):1556-62. PubMed ID: 11896584
[TBL] [Abstract][Full Text] [Related]
24. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.
Mandal R; Kohoutova K; Petrvalska O; Horvath M; Srb P; Veverka V; Obsilova V; Obsil T
Protein Sci; 2022 May; 31(5):e4287. PubMed ID: 35481640
[TBL] [Abstract][Full Text] [Related]
25. Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.
Krois AS; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11302-E11310. PubMed ID: 30420502
[TBL] [Abstract][Full Text] [Related]
26. Solution conformation of an essential region of the p53 transactivation domain.
Botuyan MV; Momand J; Chen Y
Fold Des; 1997; 2(6):331-42. PubMed ID: 9427007
[TBL] [Abstract][Full Text] [Related]
27. Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin.
Onuma H; Vander Kooi BT; Boustead JN; Oeser JK; O'Brien RM
Mol Endocrinol; 2006 Nov; 20(11):2831-47. PubMed ID: 16840535
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
29. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
[TBL] [Abstract][Full Text] [Related]
30. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
[TBL] [Abstract][Full Text] [Related]
31. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.
Scheijen B; Ngo HT; Kang H; Griffin JD
Oncogene; 2004 Apr; 23(19):3338-49. PubMed ID: 14981546
[TBL] [Abstract][Full Text] [Related]
32. The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif.
Xu H; Ye H; Osman NE; Sadler K; Won EY; Chi SW; Yoon HS
Biochemistry; 2009 Dec; 48(51):12159-68. PubMed ID: 19916559
[TBL] [Abstract][Full Text] [Related]
33. Structural Basis for the Interaction between p53 Transactivation Domain and the Mediator Subunit MED25.
Lee MS; Lim K; Lee MK; Chi SW
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360415
[TBL] [Abstract][Full Text] [Related]
34. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
35. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
Laptenko O; Tong DR; Manfredi J; Prives C
Trends Biochem Sci; 2016 Dec; 41(12):1022-1034. PubMed ID: 27669647
[TBL] [Abstract][Full Text] [Related]
36. Identification of a function-specific mutation of clathrin heavy chain (CHC) required for p53 transactivation.
Ohata H; Ota N; Shirouzu M; Yokoyama S; Yokota J; Taya Y; Enari M
J Mol Biol; 2009 Dec; 394(3):460-71. PubMed ID: 19766654
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
Wu W; Zou M; Brickley DR; Pew T; Conzen SD
Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749
[TBL] [Abstract][Full Text] [Related]
38. AcFKH1, a novel member of the forkhead family, associates with the RFX transcription factor CPCR1 in the cephalosporin C-producing fungus Acremonium chrysogenum.
Schmitt EK; Hoff B; Kück U
Gene; 2004 Nov; 342(2):269-81. PubMed ID: 15527986
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for DNA recognition by FOXO proteins.
Obsil T; Obsilova V
Biochim Biophys Acta; 2011 Nov; 1813(11):1946-53. PubMed ID: 21146564
[TBL] [Abstract][Full Text] [Related]
40. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.
Schrag LG; Liu X; Thevarajan I; Prakash O; Zolkiewski M; Chen J
J Mol Biol; 2021 Jul; 433(15):167048. PubMed ID: 33984364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
